First Command Bank’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$10.1K Hold
100
﹤0.01% 341
2023
Q1
$9.2K Hold
100
﹤0.01% 334
2022
Q4
$9K Hold
100
﹤0.01% 335
2022
Q3
$8K Hold
100
﹤0.01% 339
2022
Q2
$8K Hold
100
﹤0.01% 341
2022
Q1
$9K Sell
100
-248
-71% -$21.5K ﹤0.01% 342
2021
Q4
$28K Hold
348
﹤0.01% 295
2021
Q3
$28K Hold
348
﹤0.01% 295
2021
Q2
$32K Hold
348
﹤0.01% 285
2021
Q1
$30K Sell
348
-262
-43% -$23.5K 0.01% 269
2020
Q4
$58K Hold
610
0.01% 206
2020
Q3
$53K Hold
610
0.02% 186
2020
Q2
$53K Hold
610
0.02% 186
2020
Q1
$50K Sell
610
-150
-20% -$13.4K 0.03% 187
2019
Q4
$72K Buy
760
+131
+21% +$11.8K 0.03% 185
2019
Q3
$55K Buy
629
+239
+61% +$21.5K 0.03% 198
2019
Q2
$36K Sell
390
-45
-10% -$3.81K 0.02% 227
2019
Q1
$37K Hold
435
0.02% 225
2018
Q4
$33K Hold
435
0.02% 241
2018
Q3
$34K Hold
435
0.01% 236
2018
Q2
$29K Hold
435
0.01% 251
2018
Q1
$31.5K Hold
435
0.02% 248
2017
Q4
$33K Hold
435
0.02% 238
2017
Q3
$33K Hold
435
0.02% 235
2017
Q2
$33K Hold
435
0.02% 244
2017
Q1
$29K Buy
435
+335
+335% +$22.3K 0.02% 244
2016
Q4
$7K Buy
+100
New +$6.49K 0.01% 343

Other funds holding NVS

First Command Bank's NVS Position: Q2 2023 in Review

First Command Bank held its Novartis (NVS) position steady in Q2 2023 at 100 shares worth $10.1K. The position accounts for ﹤0.01% of the portfolio, ranked #341.

First Command Bank first reported a position in NVS in Q4 2016 and has held it in 27 quarters since. The position peaked at $72K in Q4 2019. 1,202 funds tracked by Wall St. Rank hold NVS as of Q2 2023.

  • First Command Bank held 100 shares of Novartis worth $10.1K as of Q2 2023.
  • First Command Bank left its Novartis share count unchanged in Q2 2023.
  • Novartis made up ﹤0.01% of First Command Bank's portfolio in Q2 2023, its #341 holding.
  • First Command Bank first reported a position in Novartis in Q4 2016 and has held it in 27 quarters since.
  • First Command Bank's Novartis position peaked at $72K in Q4 2019.
  • 1,202 funds tracked by Wall St. Rank held Novartis as of Q2 2023.

Based on First Command Bank's 13F filing for Q2 2023, filed 21 Jul 2023.